STATE OF CALIFORNIA STATEWIDE PHARMACEUTICAL PROGRAM COMMON DRUG FORMULARY

First Page		Document Content
Date: 2016-02-29 20:46:17 Pharmacology Clinical medicine Medicine RTT Sodium channel blockers Pharmacy Formulary Beta blocker Drug class Pharmaceutical drug Inotrope Cephalosporin		STATE OF CALIFORNIA STATEWIDE PHARMACEUTICAL PROGRAM COMMON DRUG FORMULARY Add to Reading List Source URL: www.documents.dgs.ca.gov Download Document from Source Website File Size: 272,72 KB Share Document on Facebook

	Application of Natural Resources to Drug Discovery in Eisai Research and Development of Eribulin mesylate Katsuya Tagami, Eisai Co., Ltd. Eribuin mesylate is a first-in class, non-taxane microtubule dynamics inhibitor th DocID: 1uZFZ - View Document
	AprilMedications Requiring Prior Authorization for Medical Necessity for Clients with Advanced Control Specialty Formulary™ Below is a list of medicines by drug class that will not be covered without a prior aut DocID: 1uVOq - View Document
	Commonly Requested Special Authorization Drugs Therapeutic Category/ Drug Class DocID: 1uctK - View Document
	Letters RESEARCH LETTER Presence of Banned Drugs in Dietary Supplements Following FDA Recalls The US Food and Drug Administration (FDA) initiates class I DocID: 1sToy - View Document
	PRESS RELEASE Bicycle Therapeutics announces £20M ($32M) million financing for drug development Cambridge, UK, 14th OctoberBicycle Therapeutics, a next generation biotherapeutics company developing first-in-class DocID: 1rEWy - View Document